TIAA CREF Investment Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$61.2M	Buy	384,925 +232,926	+153%	+$33.7M	0.04%	357
2018 Q4	$14.6M	Sell	151,999 -17,706	-10%	-$2.03M	0.01%	784
2018 Q3	$24M	Sell	169,705 -13,379	-7%	-$2.07M	0.02%	665
2018 Q2	$28.7M	Sell	183,084 -47,511	-21%	-$7.46M	0.02%	606
2018 Q1	$37.1M	Buy	230,595 +102,805	+80%	+$17.5M	0.03%	529
2017 Q4	$21M	Buy	127,790 +7,276	+6%	+$705K	0.01%	768
2017 Q3	$7.51M	Sell	120,514 -2,040	-2%	-$160K	0.01%	1345
2017 Q2	$9.76M	Buy	122,554 +21,527	+21%	+$1.56M	0.01%	1150
2017 Q1	$7.18M	Sell	101,027 -1,840	-2%	-$108K	0.01%	1347
2016 Q4	$5.25M	Buy	102,867 +602	+0.6%	+$28.4K	﹤0.01%	1565
2016 Q3	$4.71K	Buy	102,265 +13,744	+16%	+$559K	﹤0.01%	1650
2016 Q2	$2.67M	Buy	88,521 +34,248	+63%	+$1.14M	﹤0.01%	1951
2016 Q1	$1.74M	Buy	54,273 +3,227	+6%	+$114K	﹤0.01%	2161
2015 Q4	$2.98M	Sell	51,046 -8,282	-14%	-$410K	﹤0.01%	1908
2015 Q3	$2.51M	Buy	59,328 +14,783	+33%	+$911K	﹤0.01%	2010
2015 Q2	$3.25M	Buy	44,545 +28,284	+174%	+$1.82M	﹤0.01%	1983
2015 Q1	$817K	Buy	16,261 +1,865	+13%	+$80.2K	﹤0.01%	2728
2014 Q4	$527K	Buy	14,396 +2,099	+17%	+$78.2K	﹤0.01%	2947
2014 Q3	$387K	Buy	+12,297	New	+$356K	﹤0.01%	3023